Eduardo R Butelman1, Carina Y Chen2, Kate G Brown2, Mary Jeanne Kreek2. 1. Laboratory of the Biology of Addictive Diseases, the Rockefeller University, New York NY, United States. Electronic address: butelme@rockefeller.edu. 2. Laboratory of the Biology of Addictive Diseases, the Rockefeller University, New York NY, United States.
Abstract
BACKGROUND: Persons dually diagnosed with opioid and cocaine dependence (OD + CD) present a clinical challenge and are at risk of morbidity and mortality. The time of escalation of heroin and cocaine exposure in persons with OD + CD remain understudied, and the influence of gender and other variables have not been examined. This observational study focused on the time of escalation of heroin and cocaine in volunteers with OD + CD, examining gender and exposure to other drugs (e.g., cannabis or alcohol) as predictors. Ages of first use and of onset of heaviest use of each drug were collected (in whole years). Time of escalation was defined as the interval between age of first use and onset of heaviest use. VOLUNTEERS: sequentially ascertained adult volunteers recruited from the New York Metropolitan area, of which n = 297 were diagnosed with OD + CD. METHODS: Instruments administered were the SCID-I diagnostic interview (DSM-IV criteria), BIS-11 impulsiveness scale, and KMSK scales, dimensional measures of maximal exposure to specific drugs. RESULTS: In volunteers with OD + CD, ages of onset of heaviest use of cannabis (median age = 15) and alcohol (median age = 19) were in adolescence or emerging adulthood and preceded those for heroin and cocaine (median ages = 26 and 25, respectively). Maximal levels of cannabis and alcohol exposure were high, in volunteers with OD + CD. In adjusted Cox regressions, gender was not a significant predictor of time of heroin or cocaine escalation. However, more rapid time of alcohol escalation was a predictor of more rapid time of escalation of both heroin and cocaine, in volunteers with OD + CD.
BACKGROUND:Persons dually diagnosed with opioid and cocaine dependence (OD + CD) present a clinical challenge and are at risk of morbidity and mortality. The time of escalation of heroin and cocaine exposure in persons with OD + CD remain understudied, and the influence of gender and other variables have not been examined. This observational study focused on the time of escalation of heroin and cocaine in volunteers with OD + CD, examining gender and exposure to other drugs (e.g., cannabis or alcohol) as predictors. Ages of first use and of onset of heaviest use of each drug were collected (in whole years). Time of escalation was defined as the interval between age of first use and onset of heaviest use. VOLUNTEERS: sequentially ascertained adult volunteers recruited from the New York Metropolitan area, of which n = 297 were diagnosed with OD + CD. METHODS: Instruments administered were the SCID-I diagnostic interview (DSM-IV criteria), BIS-11impulsiveness scale, and KMSK scales, dimensional measures of maximal exposure to specific drugs. RESULTS: In volunteers with OD + CD, ages of onset of heaviest use of cannabis (median age = 15) and alcohol (median age = 19) were in adolescence or emerging adulthood and preceded those for heroin and cocaine (median ages = 26 and 25, respectively). Maximal levels of cannabis and alcohol exposure were high, in volunteers with OD + CD. In adjusted Cox regressions, gender was not a significant predictor of time of heroin or cocaine escalation. However, more rapid time of alcohol escalation was a predictor of more rapid time of escalation of both heroin and cocaine, in volunteers with OD + CD.
Authors: Christina Marel; Matthew Sunderland; Katherine L Mills; Tim Slade; Maree Teesson; Cath Chapman Journal: Drug Alcohol Depend Date: 2018-11-03 Impact factor: 4.492
Authors: Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant Journal: Am J Psychiatry Date: 2013-08 Impact factor: 18.112
Authors: Eduardo Roque Butelman; Silvia Bacciardi; Angelo Giovanni Icro Maremmani; Maya Darst-Campbell; Joel Correa da Rosa; Mary Jeanne Kreek Journal: Am J Addict Date: 2017-06-27
Authors: Eduardo R Butelman; Carina Y Chen; Rebecca S Fry; Rachel Kimani; Orna Levran; Jürg Ott; Joel Correa da Rosa; Mary Jeanne Kreek Journal: Drug Alcohol Depend Date: 2018-07-21 Impact factor: 4.492
Authors: Robert Whelan; Richard Watts; Catherine A Orr; Robert R Althoff; Eric Artiges; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Christian Büchel; Fabiana M Carvalho; Patricia J Conrod; Herta Flor; Mira Fauth-Bühler; Vincent Frouin; Juergen Gallinat; Gabriela Gan; Penny Gowland; Andreas Heinz; Bernd Ittermann; Claire Lawrence; Karl Mann; Jean-Luc Martinot; Frauke Nees; Nick Ortiz; Marie-Laure Paillère-Martinot; Tomas Paus; Zdenka Pausova; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Andreas Ströhle; Gunter Schumann; Hugh Garavan Journal: Nature Date: 2014-07-02 Impact factor: 49.962
Authors: Eduardo R Butelman; Carina Y Chen; Kimberly J Lake; Kate G Brown; Mary Jeanne Kreek Journal: Exp Clin Psychopharmacol Date: 2020-10-29 Impact factor: 3.157
Authors: Vadim Yuferov; Eduardo R Butelman; Matthew Randesi; Wim van den Brink; Peter Blanken; Jan M van Ree; Mary Jeanne Kreek Journal: Neuropsychiatr Dis Treat Date: 2021-02-25 Impact factor: 2.570
Authors: Elise E DeVito; Andrea H Weinberger; Raina D Pang; Nicole Petersen; Tessa Fagle; Alicia M Allen Journal: Curr Behav Neurosci Rep Date: 2020-07-15